An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma.

[1]  J. Sarkaria,et al.  The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma , 2015, Clinical Cancer Research.

[2]  W. Zeng,et al.  Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies , 2012, Analytical and Bioanalytical Chemistry.

[3]  M. Matyska,et al.  A new approach to bioanalysis: aqueous normal-phase chromatography with silica hydride stationary phases. , 2012, Bioanalysis.

[4]  J. Aten,et al.  In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. , 2010, Cancer cell.

[5]  J. Schellens,et al.  Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents. , 2010, Current clinical pharmacology.

[6]  P. LoRusso,et al.  Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  Tsuyoshi Arai,et al.  Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents , 2009, Molecular Cancer Therapeutics.

[8]  Anders Tunek,et al.  High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. , 2007, Journal of medicinal chemistry.

[9]  Chi-Tang Ho,et al.  Separation of amino acids, peptides and corresponding Amadori compounds on a silica column at elevated temperature. , 2007, Journal of chromatography. A.

[10]  T. Kanda,et al.  Retention behavior of oligomeric proanthocyanidins in hydrophilic interaction chromatography. , 2007, Journal of chromatography. A.

[11]  M. Hidalgo,et al.  Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients , 2006, Investigational New Drugs.

[12]  W. Naidong,et al.  Bioanalytical liquid chromatography tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  A. Alpert.  Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. , 1990, Journal of chromatography.